The study is to assess whether we can use a cancer-associated carbon-hydrate directed imaging technique to detect the most aggressive prostate tumors using pre-clinical models and to determine whether the cancer-associated carbon-hydrate is an therapeutic target as well in preclinical animal models.
|Effective start/end date||9/30/19 → 9/29/22|
- Washington University St. Louis (WU-20-307-MOD-1//W81XWH1910795)
- U.S. Army Medical Research and Materiel Command (WU-20-307-MOD-1//W81XWH1910795)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.